SYRS
Syros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Mar 26, 2025
- EPS actual
- -$1.19
- EPS estimate
- -$0.70
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -17.2%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 26, 2025 | -$0.70 | -$1.19 | Miss -70.00% | — |
| Oct 31, 2024 | -$0.76 | -$0.68 | Beat 10.53% | — |
| Jul 31, 2024 | -$0.79 | -$0.70 | Beat 11.39% | — |
| Nov 14, 2023 | -$1.12 | -$1.35 | Miss -20.54% | $3.8M |
| Mar 2, 2023 | -$1.27 | -$1.28 | Miss -0.79% | -$5.5M |
| Nov 14, 2022 | -$3.91 | -$2.41 | Beat 38.36% | $3.9M |
| May 16, 2022 | -$4.80 | -$4.00 | Beat 16.67% | $5.5M |
| Mar 15, 2022 | -$4.40 | -$4.20 | Beat 4.55% | $7.8M |
| Nov 5, 2021 | -$4.30 | -$4.10 | Beat 4.65% | $5.7M |
| Aug 5, 2021 | -$3.60 | -$3.60 | In line | $5.2M |
| May 6, 2021 | -$5.50 | -$2.30 | Beat 58.18% | $4.8M |
| Mar 4, 2021 | -$5.40 | -$6.10 | Miss -12.96% | $5.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026